Triple-negative breast cancer cell cadavers, conjugated with anti-PD-1 antibodies and doxorubicin (DOX)-loaded liposomes using small-molecule chemical cross-linkers, could target tumor metastases in the lungs through adhesion proteins on their surfaces [134]. The gene discussed is PDCD1; the disease is neoplasm.